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SseA, the translation product of the Escherichia coli sseA gene, is a
31 kDa protein endowed with 3-mercaptopyruvate:cyanide sulfur-
transferase activity in vitro. As such, SseA is the prototype of a
sulfurtransferase subfamily distinguished from the better known
rhodanese sulfurtransferases, which display thiosulfate:cyanide
sulfurtransferase activity. The physiological role of the two homo-
logous enzyme families, whose catalytic activity is centred on a
reactive invariant cysteine, is a matter of debate. In this framework,
the forthcoming crystal structure analysis of SseA will be based on the
tetragonal crystal form (space group P41 or P43) reported here, with
unit-cell parameters a = b = 150.2, c = 37.9 AÊ .
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1. Introduction
Sulfurtransferases (EC 2.8.1.x) are a class of
enzymes widely distributed among living
organisms that catalyze the in vitro transfer of
a sulfane S atom from a suitable donor mole-
cule to a nucleophilic acceptor (Westley, 1977;
Westley et al., 1983). Of the sulfurtransferases,
bovine rhodanese (thiosulfate:cyanide sulfur-
transferase; TST; EC 2.8.1.1) is the best char-
acterized enzyme (Lang, 1933; SoÈ rbo, 1960;
Ploegman et al., 1978; Gliubich et al., 1998).
Rhodanese catalyzes the transfer of a sulfane S
atom from thiosulfate to cyanide. The reaction
occurs via formation of a covalent enzyme±
sulfur intermediate, with the persul®de S atom
covalently bound to the thiol group of the
catalytic Cys residue. The physiological role of
rhodanese is still under debate, since it appears
unlikely that such a ubiquitous enzyme is
uniquely involved in cyanide detoxi®cation, as
originally proposed. In this regard, the enzyme
displays rather a wide substrate speci®city.
Various thiosulfonates or polythionates may
act as sulfur donors, while sul®te and thiol
compounds may replace cyanide as the sulfane
sulfur acceptor (Ploegman, 1977).
A related sulfurtransferase enzyme,
3-mercaptopyruvate:cyanide sulfurtransferase
(MST; EC 2.8.1.2), catalyzes a reaction similar
to rhodanese in which thiosulfate is replaced
by 3-mercaptopyruvate (1).
HSCH2COCOO
ÿ  CNÿ !
CH3COCOO
ÿ  CNSÿ: 1
MST activity was identi®ed quite a long time
ago (Meister et al., 1954); it was also shown
that, similar to rhodanese, nucleophilic
compounds other than cyanide may act as
sulfur acceptors in the same reaction (Kun &
Fanshier, 1959). Even although MST activity
has been found to be widely distributed in
prokaryotes and eukaryotes (Wood & Fiedler,
1953; Jarabak & Westley, 1978; Westley et al.,
1983), only eukaryotic MST enzymes from rat
and Arabidopsis thaliana have been
biochemically characterized to date (Nagahara
et al., 1995; Nagahara & Nishino, 1996;
Papenbrock & Schmidt, 2000a,b; Nakamura et
al., 2000). Probably owing to intrinsic enzyme
instability, little has been reported to date
about the chemical mechanism of MST cata-
lysis (Jarabak & Westley, 1978, 1980; Nagahara
et al., 1999).
Signi®cant sequence similarity is found
between MST and TST enzymes (rat MST and
TST have a sequence identity of 59%; Naga-
hara et al., 1995), including a conserved
(putatively) catalytic Cys residue at equivalent
locations in the respective amino-acid
sequences. From a phylogenetic viewpoint, this
observation indicates that the two enzymes
share a common ancestor and are likely to
adopt similar three-dimensional folds (Naga-
hara et al., 1995; Bordo & Bork, 2002).
Structural studies carried out on bovine and
Azotobacter vinelandii rhodanese (Ploegman
et al., 1978; Bordo et al., 2000) have shown that
TSTs are composed of two similarly folded
domains, each about 120 amino acids long, with
the invariant catalytic Cys residue located in
the C-terminal domain. The catalytic Cys is the
®rst residue of a six-amino-acid loop that folds
in a cradle-like structure around the thiol
group of the essential Cys. Although the resi-
dues surrounding the active site are deemed to
be important for substrate speci®city and
enzyme activity, bovine and A. vinelandii TSTs
have widely differing sequences in the active-
site loop (CRKGVT compared with
CQTHHR, respectively). In contrast, the
characterized MST enzymes display the
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conserved active-site loop sequence
CG[S/T]GVT ([S/T] indicates the occur-
rence of either Ser or Thr), suggesting a
stronger evolutionary pressure for active-
site-loop residue conservation (Bordo &
Bork, 2002).
The identi®cation and cloning of the
Escherichia coli sseA gene (Hama et al.,
1994) and the recent biochemical char-
acterization of the corresponding MST
protein, SseA (31 kDa, 280 amino acids),
allowed the identi®cation of the ®rst
prokaryotic protein to show 3-mercapto-
pyruvate:cyanide sulfurtransferase activity
in vitro (Colnaghi et al., 2001). In SseA the
active-site loop composition is also identical
to that observed in eukaryotic enzymes
(CGSGVT). As expected, SseA displays
clear sequence similarity with bovine and
A. vinelandii TSTs (35% and 27% identical
residues, respectively; Fig. 1), indicating a
similarly arranged tandem domain confor-
mation.
The determination of the three-dimen-
sional structure of SseA, the ®rst member of
the MST enzyme subfamily to be analyzed
by X-ray crystallography, will help to
elucidate the catalytic mechanism and the
structural determinants involved in MST
substrate speci®city. Here, we describe the
crystallization of SseA from E. coli, together
with a preliminary analysis of the X-ray
diffraction data.
2. Methods and results
2.1. Protein expression and purification
The sseA gene (SWISS-PROT sequence
accession No. P31142) was cloned and
overexpressed as described by Colnaghi
et al. (2001). The extract (8 ml, 20 mg mlÿ1
protein concentration) from a BL21(DE3)
(pEN1) induced culture was fractionated
overnight on a column of Sephacryl HR
S-200 (Pharmacia Biotech, Sweden) equili-
brated in 50 mM Tris±HCl buffer pH 8.0
containing 0.3 M NaCl. The fractions
displaying 3-mercaptopyruvate:cyanide sul-
furtransferase activity were pooled and
brought to 75% saturation with ammonium
sulfate. Further puri®cation of E. coli SseA
was achieved by HPLC gel ®ltration of the
ammonium sulfate precipitate solubilized in
15 ml 50 mM Tris±HCl buffer pH 8.0
containing 0.1 M NaCl (3 mg mlÿ1 protein
concentration). 200 ml aliquots of this
material were chromatographed on a
Superdex 75HR column (Pharmacia)
previously equilibrated in the solubilization
buffer. MST activity was assessed using the
discontinuous method (Jarabak, 1981) that
quantitates the product thiocyanate based
on the absorption of the ferric thiocyanate
complex at 460 nm. Assays lasted 1±2 min;
one unit (U) of enzyme is de®ned as the
amount of enzyme that produces 1 mM
thiocyanate per minute at 310 K. Protein
concentration was determined by a dye-
binding colorimetric assay (Bradford, 1976).
2.2. Crystallization
For crystallization purposes, the protein
was concentrated to 13.6 mg mlÿ1 in a buffer
containing 50 mM Tris±HCl pH 8.0 and
50 mM NaCl. Na2S2O3 was added to the
protein to a ®nal concentration of 5 mM.
Crystals were grown by the hanging-drop
vapor-diffusion method by mixing an equal
amount (1 ml) of protein and reservoir
solutions. Initial crystallization conditions
were determined by the sparse-matrix
method (Jancarik & Kim, 1991) as imple-
mented in Hampton Crystal Screens I and II
(Hampton Research, CA, USA). The opti-
mization of the preliminary crystallization
conditions resulted in crystals of optimal
size, having square rod shapes and typical
dimensions of 0.07  0.07  0.75 mm,
which grew after 10 d equilibration against
a reservoir solution containing 1.9 M
(NH4)2SO4, 40 mM MES pH 6.2, 2%(v/v)
PEG 400 and 10 mM MnCl2 at 294 K (Fig. 2).
The presence of 5 mM Na2S2O3 in the
protein solution was essential to avoid
the formation of amorphous precipitates
preventing crystal formation. This is likely to
be ascribable to the intrinsic propensity of
the reduced thiol group of Cys237 to form
interchain disul®de bridges. Sulfane sulfur-
donor compounds such as S2O
2ÿ
3 keep
the enzyme in the persulfurated form,
preventing aggregation/unfolding (Bordo et
al., 2001).
2.3. Data collection and processing
X-ray diffraction data were collected at
100 K after immersion of SseA crystals in
paraf®n oil for cryoprotection. Data collec-
tions were carried out on the ID14-4 and
BW7A synchrotron beamlines at ESRF,
Grenoble and DESY, Hamburg, respec-
tively, to a resolution limit of 2.8 AÊ (the
X-ray detector types used were ADSC Q4R
and MAR CCD, respectively). Data were
indexed and processed using DENZO and
SCALEPACK, respectively (Otwinowski,
1993; Otwinowski & Minor, 1997); further
data manipulations were performed using
programs from the CCP4 suite (Collabora-
tive Computational Project, Number 4,
1994). SseA crystals belong to the tetragonal
space group P41 (or P43), with unit-cell
parameters a = b = 150.2, c = 37.9 AÊ ,
 =  =  = 90. Calculation of the crystal
packing parameter (Matthews, 1968) indi-
cates that the crystal lattice accommodates
either two or three molecules per
asymmetric unit (VM = 3.5 or 2.3 AÊ
3 Daÿ1;
solvent contents are 65% or 47%, respec-
tively). The  = 120 section of the SseA
Figure 1
Multiple sequence alignment of SseA, bovine and A. vinelandii rhodanese enzymes (accession Nos. P31142,
P00586 and P52197, respectively). Residues assuming -strand and -helix conformation in the two TST
structures (PDB entries 1rhs and 1e0c, respectively) are shown with gray and black backgrounds, respectively.
Asterisks indicate conserved amino acids. Active-site loop residues are included in a box. Conventional labels for
secondary-structure elements (Bordo et al., 2000) and SseA amino-acid numbering are shown on the top lines.
Sequences were aligned with the program CLUSTAL_W (Thomson et al., 1994).
Figure 2
Crystals of SseA. Typical crystal dimensions are
0.75  0.07  0.07 mm.
170 Spallarossa et al.  SseA Acta Cryst. (2003). D59, 168±170
crystallization papers
self-rotation function, calculated in the 10.0±
3.5 AÊ resolution range, does not display any
signi®cant peak. On the other hand, the
 = 180 section shows peaks at the 4 level
compatible with the location of non-
crystallographic twofold axes in the unit-cell
ab plane, suggesting that a SseA dimer is
present in the asymmetric unit. Data-
collection statistics are given in Table 1.
Elucidation of the SseA structure is
presently under way via molecular-
replacement methods (Navaza, 1994;
Kissinger et al., 2001; Vagin & Teplyakov,
1997). For this purpose, the sequence align-
ment of SseA with bovine and A. vinelandii
TSTs (Gliubich et al., 1998; Bordo et al.,
2000) (Fig. 1) is being used to deduce
suitable search models.
Data collections at ESRF, Grenoble and
EMBL c/o DESY, Hamburg were supported
by the EU program `Access to Research
Infrastructure Action'. This research was
supported by the Italian Ministry of
University (PRIN Project `Sulfotransferasi
Procariotiche') and by the Italian Space
Agency (IR-167-01).
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Table 1
X-ray data-collection statistics.
Data in parentheses are for the last resolution shell
(2.85±2.80 AÊ ).
Resolution limit (AÊ ) 2.8
X-ray source ID14-4, ESRF, Grenoble
Wavelength (AÊ ) 0.9393
Space group P41/P43
Unit-cell parameters (AÊ , ) a = b = 150.2, c = 37.9,
 =  =  = 90
Mosaicity () 0.66
No. of observations 312079
Unique re¯ections 21524
Data completeness (%) 95.6 (97.9)
hI/(I)i 15.9 (2.2)
Rsym² (%) 6.6 (48.3)
² Rsym =
P
i;h jIh ÿ hIhij=
PIi , where I is the observed
intensity of the hth re¯ection.
